CURES WITHIN REACH – Clinical Trials to Validate AI-Driven Drug Repurposing (RFP’s 2025)

Accepting submissions of investigator-initiated, proof of concept, Phase I or Phase IIA clinical trials to validate artificial intelligence (AI)-driven repurposing opportunities in any unsolved diseases, where the therapies supported by AI models are already approved.

Budget: Up to USD 100.000

Any unsolved disease is eligible, although there is a preference for rare diseases. Both on-and-off patent drugs and biologics are eligible, although there is a preference for off-patent. Data from any AI model is eligible. although there is a preference for openly accessible models and for models developed by nonprofits/government.

Deadline: August 25, 2025 at 6:59 pm EST